IL141996A0 - Moraxella catarrhalis basb034 polypeptides and uses thereof - Google Patents

Moraxella catarrhalis basb034 polypeptides and uses thereof

Info

Publication number
IL141996A0
IL141996A0 IL14199699A IL14199699A IL141996A0 IL 141996 A0 IL141996 A0 IL 141996A0 IL 14199699 A IL14199699 A IL 14199699A IL 14199699 A IL14199699 A IL 14199699A IL 141996 A0 IL141996 A0 IL 141996A0
Authority
IL
Israel
Prior art keywords
immunogenic fragments
basb034 polypeptides
polypeptides
moraxella catarrhalis
seq
Prior art date
Application number
IL14199699A
Other languages
English (en)
Original Assignee
Smithkline Beecham Biolog
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Biolog filed Critical Smithkline Beecham Biolog
Publication of IL141996A0 publication Critical patent/IL141996A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/22Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/21Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
    • C07K14/212Moraxellaceae, e.g. Acinetobacter, Moraxella, Oligella, Psychrobacter
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/16Otologicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Cosmetics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL14199699A 1998-09-14 1999-09-14 Moraxella catarrhalis basb034 polypeptides and uses thereof IL141996A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9820002.5A GB9820002D0 (en) 1998-09-14 1998-09-14 Novel compounds
PCT/EP1999/006781 WO2000015802A1 (en) 1998-09-14 1999-09-14 Moraxella catarrhalis basb034 polypeptides and uses thereof

Publications (1)

Publication Number Publication Date
IL141996A0 true IL141996A0 (en) 2002-03-10

Family

ID=10838841

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14199699A IL141996A0 (en) 1998-09-14 1999-09-14 Moraxella catarrhalis basb034 polypeptides and uses thereof

Country Status (21)

Country Link
US (2) US6600013B1 (zh)
EP (1) EP1114160B1 (zh)
JP (1) JP2002525057A (zh)
KR (1) KR20010085794A (zh)
CN (1) CN1198931C (zh)
AT (1) ATE312923T1 (zh)
AU (1) AU752667B2 (zh)
BR (1) BR9914492A (zh)
CA (1) CA2342398A1 (zh)
CZ (1) CZ2001927A3 (zh)
DE (1) DE69928947T2 (zh)
ES (1) ES2253911T3 (zh)
GB (1) GB9820002D0 (zh)
HU (1) HUP0103945A3 (zh)
IL (1) IL141996A0 (zh)
NO (1) NO20011263L (zh)
NZ (1) NZ510512A (zh)
PL (1) PL347943A1 (zh)
TR (1) TR200100741T2 (zh)
WO (1) WO2000015802A1 (zh)
ZA (1) ZA200102108B (zh)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9812163D0 (en) 1998-06-05 1998-08-05 Smithkline Beecham Biolog Novel compounds
GB0103171D0 (en) 2001-02-08 2001-03-28 Smithkline Beecham Biolog Vaccine composition
WO2004015099A2 (en) 2002-08-02 2004-02-19 Glaxosmithkline Biologicals Sa Vaccine composition comprising lipooligosaccharide with reduced phase variability
AU2003298475A1 (en) * 2002-11-14 2004-06-18 Adherex Technologies, Inc. Compounds and methods for modulating desmosomal and atypical cadherin-mediated cell adhesion
TWI457133B (zh) 2005-12-13 2014-10-21 Glaxosmithkline Biolog Sa 新穎組合物
WO2024017827A1 (en) 2022-07-19 2024-01-25 Glaxosmithkline Biologicals Sa Continuous process for vaccine production

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0948625B1 (en) * 1996-12-20 2011-01-26 The Board Of Regents, The University Of Texas System Uspa1 and uspa2 antigens of moraxella catarrhalis
US6673910B1 (en) * 1999-04-08 2004-01-06 Genome Therapeutics Corporation Nucleic acid and amino acid sequences relating to M. catarrhalis for diagnostics and therapeutics
CA2378687A1 (en) * 1999-06-18 2000-12-28 Elitra Pharmaceuticals, Inc. Nucleotide sequences of moraxella catarrhalis genome
CA2311201A1 (en) * 1999-08-05 2001-02-05 Genset S.A. Ests and encoded human proteins

Also Published As

Publication number Publication date
EP1114160A1 (en) 2001-07-11
GB9820002D0 (en) 1998-11-04
US20030180317A1 (en) 2003-09-25
PL347943A1 (en) 2002-04-22
CZ2001927A3 (cs) 2001-08-15
ES2253911T3 (es) 2006-06-01
NO20011263D0 (no) 2001-03-13
JP2002525057A (ja) 2002-08-13
AU5863299A (en) 2000-04-03
NZ510512A (en) 2002-10-25
EP1114160B1 (en) 2005-12-14
ATE312923T1 (de) 2005-12-15
US7432366B2 (en) 2008-10-07
AU752667B2 (en) 2002-09-26
US6600013B1 (en) 2003-07-29
ZA200102108B (en) 2002-10-23
CA2342398A1 (en) 2000-03-23
DE69928947T2 (de) 2006-06-29
WO2000015802A1 (en) 2000-03-23
CN1198931C (zh) 2005-04-27
DE69928947D1 (de) 2006-01-19
TR200100741T2 (tr) 2001-09-21
NO20011263L (no) 2001-04-30
HUP0103945A2 (hu) 2002-02-28
CN1326509A (zh) 2001-12-12
KR20010085794A (ko) 2001-09-07
HUP0103945A3 (en) 2003-11-28
BR9914492A (pt) 2001-06-26

Similar Documents

Publication Publication Date Title
BG102983A (en) Extramembrane protein 106 polypeptide of moraxella catarrhalis, its gene sequence and application
AUPP051497A0 (en) Antimicrobial peptides
NZ333999A (en) GnRH-leukotoxin chimeric proteins for use in vaccines
CA2193210A1 (en) Method of inducing an immune response with a live venezuelan equine encephalitis virus expressing a heterologous immunogen
WO1998004702A3 (en) Proteins, in particular membrane proteins, of helicobacter pylori, their preparation and use
EP1420821B8 (en) Immunologically significant herpes simplex virus antigens and methods for using same
GB9911683D0 (en) Antigenic peptides
EP2011510A3 (en) Pharmaceutical compositions comprising immunologically active herpes simplex virus (HSV) protein fragments
CA2248667A1 (en) Hla-a2.1 binding peptides and their uses
EP0733071A4 (en) ANTAGONISTS OF CHAPERONINE 10
PL347943A1 (en) Moraxella catarrhalis basb034 polypeptides and uses thereof
EP0161007A3 (en) Retro - inverso c-terminal hexapeptide analogues of substance p
HU9801384D0 (en) Clostridium perfringeus vaccine
AU5776799A (en) Modified hcv peptide vaccines
AU1749292A (en) Recombinant hybrid porin epitopes
EA200100395A1 (ru) Фармацевтическая композиция, содержащая фрагменты днк, кодирующей антигенный белок, обладающая противоопухолевым действием
NZ507983A (en) A polypeptide comprising the amino acid of an n- terminal choline binding protein a truncate, vaccine derived therefrom and uses thereof
IL129368A0 (en) Immunogenic TLP composition
DE60036676D1 (de) G-protein-gekoppelter rezeptor-ähnliche proteine
MY107451A (en) Cloning and expression of a rhoptry associated protein of p.falciparum
ZA896942B (en) Allelic variants of plasmodium falciparum merozoite surface antigen
DE60223232D1 (de) Mucinpeptid mit immunstärkenden eigenschaften
WO2000026240A3 (en) Streptococcal alpha2m-binding protein
WO2003000718A3 (en) Polypeptides comprising t cell epitopes from alpha-fodrin and the uses thereof in treatment of sjögren's syndrome
GB2341606A (en) Glycosylation peptides